| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.00028 | 1 |